flunarizine

This page covers all flunarizine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adenosine receptor A3, CAAX prenyl protease 2, 5-hydroxytryptamine receptor 1A.

Targets

Adenosine receptor A3, CAAX prenyl protease 2, 5-hydroxytryptamine receptor 1A

Phase 2 pipeline (1)

• Sibelium · Pain
  Flunarizine works by binding to the Sigma non-opioid intracellular receptor 1, which is involved in various cellular processes.

Patent intelligence

• flunarizine patent landscape — aggregated cliff calendar, attackable patents, originator estates